Category: Patient News
Medical news and safety updates for patients and the public.
-
TGA proposes clearer labels and stronger warnings for vitamin B6 supplements
The TGA is consulting until 25 November 2026 on clearer vitamin B6 labels and stronger nerve-damage warnings. What is proposed, what is already decided, and what it means for you.
-
HRT patch shortage update: Estradot supply now expected to recover by mid-2027
The TGA has extended its estimated shortage of several Estradot HRT patch strengths to 30 June 2027. Here is what changed, how pharmacist substitution works and what to keep in mind.
-
Weight training reduced muscle loss and improved strength during tirzepatide treatment, Australian trial finds
A 40-week Australian randomised trial found supervised resistance training alongside tirzepatide reduced lean tissue loss by about 1.1 kg and improved strength, with similar weight loss. What it means and its limits.
-
Draft national virtual care standards open for public comment — Patients
Australia’s safety commission is consulting on draft standards for telehealth and other remote care until 13 December 2026.
-
Bicillin L-A shortage: updated Australian supply advice — Patients
The TGA’s updated advice on an ongoing injectable antibiotic shortage, overseas alternatives and the need for individual suitability assessment.
-
TGA warns against Synedica peptides after label discrepancies found — Public
TGA laboratory findings highlight unreliable Synedica peptide labels: the regulator’s advice and the limits of the evidence, explained for the public.